Corticalis AS

Corticalis AS was founded in 2006 by leading researchers and clinicians with extensive experience in the development and marketing of dental implants and regenerative therapies. The company's mission is to develop innovative and sustainable medical devices designed for professional care of patients treated for oral diseases as well as wounds on the skin and mucous membranes. Corticalis places a particular emphasis on developing and promoting alternatives to the use of antibiotics and antimicrobial agents. The increasing use of antibiotics contributes to bacteria and microbes becoming resistant to medications. Corticalis provides effective alternatives to antibiotics to help address this growing problem. The company currently offers ready-to-use products for the maintenance treatment of teeth and dental implants affected by gum inflammation. Corticalis has also developed a nature-inspired, non-animal product for surgical reconstruction of supporting tissue around teeth and dental implants that has been lost due to disease. These products are to be marketed through a global network of established distributors.